Shadia I. Jalal Department of Medicine, Medical Oncology Division Indiana University Melvin and Bren Simon Cancer Center Biography Publications Institution JoVE Articles Shadia I. Jalal has not added a biography. If you are Shadia I. Jalal and would like to personalize this page please email our Author Liaison for assistance. Publications Breakthroughs and Challenges in the Management of Tropomyosin Receptor Kinase Fusion-positive Tumors Annals of Translational Medicine. Jul, 2019 | Pubmed ID: 31576362 Social Correlates of Mental Health in Gastrointestinal Cancer Patients and Their Family Caregivers: Exploring the Role of Loneliness Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. Jun, 2019 | Pubmed ID: 30225573 Evofosfamide for the Treatment of Human Papillomavirus-negative Head and Neck Squamous Cell Carcinoma JCI Insight. 08, 2018 | Pubmed ID: 30135316 Outcomes of a Novel Intrathoracic Esophagogastric Anastomotic Technique The Journal of Thoracic and Cardiovascular Surgery. 10, 2018 | Pubmed ID: 30033105 Blood-based Tumor Biomarkers in Lung Cancer for Detection and Treatment Translational Lung Cancer Research. Dec, 2017 | Pubmed ID: 29218268 Phase 1 Study of Narnatumab, an Anti-RON Receptor Monoclonal Antibody, in Patients with Advanced Solid Tumors Investigational New Drugs. 08, 2017 | Pubmed ID: 28161886 Novel Therapies in Small Cell Lung Cancer Translational Lung Cancer Research. Oct, 2015 | Pubmed ID: 26629422 Locally Advanced Non-Small Cell Lung Cancer: Optimal Chemotherapeutic Agents and Duration Current Treatment Options in Oncology. Oct, 2015 | Pubmed ID: 26233240 Gastroesophageal Junction Adenocarcinoma Displays Abnormalities in Homologous Recombination and Nucleotide Excision Repair Lung Cancer (Auckland, N.Z.). 2014 | Pubmed ID: 28210138 The Role of Maintenance Chemotherapy in Advanced Nonsmall Cell Lung Cancer Current Opinion in Oncology. Mar, 2009 | Pubmed ID: 19532011 Айвор Льюис эзофагектомия предназначена для минимизации анастомотических осложнений и оптимизации функции канала Neal K. Ramchandani1, Kenneth A. Kesler1, Jonathon D. Rogers1, Nakul Valsangkar1, Samatha M. Stokes1, Shadia I. Jalal2 1Department of Surgery, Division of Cardiothoracic, Indiana University Melvin and Bren Simon Cancer Center, 2Department of Medicine, Medical Oncology Division, Indiana University Melvin and Bren Simon Cancer Center JoVE 59255 Cancer Research
Айвор Льюис эзофагектомия предназначена для минимизации анастомотических осложнений и оптимизации функции канала Neal K. Ramchandani1, Kenneth A. Kesler1, Jonathon D. Rogers1, Nakul Valsangkar1, Samatha M. Stokes1, Shadia I. Jalal2 1Department of Surgery, Division of Cardiothoracic, Indiana University Melvin and Bren Simon Cancer Center, 2Department of Medicine, Medical Oncology Division, Indiana University Melvin and Bren Simon Cancer Center JoVE 59255 Cancer Research
